Circulation, Vol 86, 1453-1463, Copyright © 1992 by American Heart Association
RW Braith, CE Wood, MC Limacher, ML Pollock, DT Lowenthal, MI Phillips and ED Staples
BACKGROUND. Osmotic and neural factors stimulate neuroendocrine activity
during exercise. In contrast to excitatory mechanisms, afferent information
from cardiac mechanoreceptors inhibits integrative centers in the
hypothalamus and medula oblongata, which serves to buffer neuroendocrine
activity. Orthotopic cardiac transplantation results in the loss of
afferent information from cardiac mechanoreceptors. Thus, transplantation
possibly results in exaggerated neuroendocrine responses when patients are
physically active. METHODS AND RESULTS. We measured the neuroendocrine
response to moderate and strenuous exercise performed at the same relative
intensity in 11 heart transplant recipients (50 +/- 14 years old) 18 +/- 12
months after transplantation and 11 control subjects matched with respect
to sex, age, and body size. Plasma levels of norepinephrine, vasopressin,
renin activity, atrial natriuretic peptide, angiotensin II, and aldosterone
were measured at rest, during a maximal graded exercise test, and during
submaximal exercise at 40% and 70% of peak power output on a cycle
ergometer (W). Plasma renin activity and atrial natriuretic peptide were
elevated at rest in heart transplant recipients (p < or = 0.05). Heart
rate (%HRmax reserve), rating of perceived exertion, and reductions in
plasma volume (% delta from rest) at the conclusion of the three exercise
conditions did not differ between heart transplant recipients and control
(p > or = 0.05). Relative changes in neuroendocrine hormones were
similar (p > or = 0.05) in heart transplant recipients and control
during exercise at 40% of peak power output. Relative changes in plasma
norepinephrine, vasopressin, atrial natriuretic peptide, and plasma renin
activity were greater (p < or = 0.05) in heart transplant recipients
during exercise at 70% of peak power output and the graded exercise test.
CONCLUSIONS. We interpret these data as a possible indication of ablation
of cardiac mechanoreceptor afferents and unopposed neuroendocrine
stimulation in heart transplant recipients. Furthermore, chronic
neuroendocrine hyperactivity is likely in ambulatory heart transplant
recipients. Although cyclosporine nephrotoxicity is implicated in the
development of hypertension, our data suggest that chronic neuroendocrine
hyperactivity, which alters renal volume regulation, also contributes to
the incidence and severity of hypertension in heart transplant recipients.
ARTICLES
Abnormal neuroendocrine responses during exercise in heart transplant recipients
Center for Exercise Science, College of Medicine, University of Florida, Gainesville 32610.
This article has been cited by other articles:
![]() |
J. Kim, A. Ogai, S. Nakatani, K. Hashimura, H. Kanzaki, K. Komamura, M. Asakura, H. Asanuma, S. Kitamura, H. Tomoike, et al. Impact of Blockade of Histamine H2 Receptors on Chronic Heart Failure Revealed by Retrospective and Prospective Randomized Studies J. Am. Coll. Cardiol., October 3, 2006; 48(7): 1378 - 1384. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Jensen, C. E. Wood, and M. Keller-Wood Alterations in Maternal Corticosteroid Levels Influence Fetal Urine and Lung Liquid Production Reproductive Sciences, December 1, 2003; 10(8): 480 - 489. [Abstract] [PDF] |
||||
![]() |
K. Node, M. Fujita, M. Kitakaze, M. Hori, and J. K. Liao Short-Term Statin Therapy Improves Cardiac Function and Symptoms in Patients With Idiopathic Dilated Cardiomyopathy Circulation, August 19, 2003; 108(7): 839 - 843. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Braith, R. M. Mills, C. S. Wilcox, G. L. Davis, J. A. Hill, and C. E. Wood High-dose angiotensin-converting enzyme inhibition restores body fluid homeostasis in heart-transplant recipients J. Am. Coll. Cardiol., February 5, 2003; 41(3): 426 - 432. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Eisen Hypertension in heart transplant recipients: more than just cyclosporine J. Am. Coll. Cardiol., February 5, 2003; 41(3): 433 - 434. [Full Text] [PDF] |
||||
![]() |
B. Geny, R. Richard, B. Mettauer, J. Lonsdorfer, and F. Piquard Cardiac natriuretic peptides during exercise and training after heart transplantation Cardiovasc Res, August 15, 2001; 51(3): 521 - 528. [Full Text] [PDF] |
||||
![]() |
O. A. Al-Rawas, R. Carter, R. D. Stevenson, S. K. Naik, and D. J. Wheatley Exercise Intolerance Following Heart Transplantation : The Role of Pulmonary Diffusing Capacity Impairment Chest, December 1, 2000; 118(6): 1661 - 1670. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Braith, R. M. Mills, C. S. Wilcox, M. J. Mitchell, J. A. Hill, and C. E. Wood High dose angiotensin-converting enzyme inhibition prevents fluid volume expansion in heart transplant recipients J. Am. Coll. Cardiol., August 1, 2000; 36(2): 487 - 492. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Braith, M. A. Welsch, M. S. Feigenbaum, H. A. Kluess, and C. J. Pepine Neuroendocrine activation in heart failure is modified by endurance exercise training J. Am. Coll. Cardiol., October 1, 1999; 34(4): 1170 - 1175. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Geny, A. Charloux, E. Lampert, J. Lonsdorfer, P. Haberey, and F. Piquard Enhanced brain natriuretic peptide response to peak exercise in heart transplant recipients J Appl Physiol, December 1, 1998; 85(6): 2270 - 2276. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Givertz, L. H. Hartley, and W. S. Colucci Long-term Sequential Changes in Exercise Capacity and Chronotropic Responsiveness After Cardiac Transplantation Circulation, July 1, 1997; 96(1): 232 - 237. [Abstract] [Full Text] |
||||
![]() |
A. E. Gamel, N. A. Yonan, B. Keevil, R. Warbuton, J. Kakadellis, A. Woodcock, C. S. Campbell, A. N. Rahman, and A. K. Deiraniya Significance of Raised Natriuretic Peptides After Bicaval and Standard Cardiac Transplantation Ann. Thorac. Surg., April 1, 1997; 63(4): 1095 - 1100. [Abstract] [Full Text] |
||||
![]() |
G. Vassalli, A. Gallino, W. Kiowski, Z. Jiang, M. Turina, and O. M. Hess Reduced Coronary Flow Reserve During Exercise in Cardiac Transplant Recipients Circulation, February 4, 1997; 95(3): 607 - 613. [Abstract] [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1992 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |